Proteomic Techniques as Biomarkers for Multiple Sclerosis

J Gordon Millichap

doi:10.15844/pedneurbriefs-26-6-10

Proteomic Techniques as Biomarkers for Multiple Sclerosis

Pediatric Neurology Briefs

Volume 26 (2012): Issue 6

By: J Gordon Millichap

Open Access

|Jun 2012

Abstract

Researchers at the Montreal Neurological Institute and other centers in Canada performed proteomics screening of CSF samples collected from 19 children at presentation of acquired inflammatory CNS demyelinating syndromes.

References

Dhaunchak AS Becker C Schulman H De Faria O Jr Rajasekharan S Banwell B Colman DR Implication of perturbed axoglial apparatus in early pediatric multiple sclerosis Ann Neurol 2012 May 71 5 601 13 10.1002/ana.22693 22473675
Open DOI Search in Google Scholar Back to article
Komori M Matsuyama Y Nirasawa T Thiele H Becker M Alexandrov T Saida T Proteomic pattern analysis discriminates among multiple sclerosis-related disorders Ann Neurol 2012 May 71 5 614 23 10.1002/ana.22633 22522477
Open DOI Search in Google Scholar Back to article
Bennett JL Owens GP Cerebrospinal fluid proteomics: a new window for understanding human demyelinating disorders? Ann Neurol 2012 May 71 5 587 8 10.1002/ana.23595 22522475
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-26-6-10 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 47 - 47

Published on: Jun 1, 2012

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Acquired CNS Demyelinating Syndrome,

Peptide Profiling,

Mass Spectroscopy

© 2012 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 26 (2012): Issue 6